Browse by author
Lookup NU author(s): Professor Alastair Hawkins
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The syntheses by Suzuki cross-coupling of 12 5-aryl analogues of the known inhibitor (LR,3/2,4R)-1,3,4-trihydroxycyclohex-5-en-1-carboxylic acid are reported. These compounds were found to be reversible competitive inhibitors against Mycobacterium tuberculosis type II dehydroquinase, the third enzyme of the shikimic acid pathway. The most potent inhibitor, the 3-nitrophenyl derivative, has a Ki of 54 nM, over 180 times more potent than the reported inhibitor (LR,3/2,4R)-5-fluoro-1,3,4-trihydroxycyclohex-5-en-1- carboxylic acid and more than 700 times lower than the KM of the substrate, making it the most potent known inhibitor against any type II dehydroquinase. Docking studies using GOLD (version 2.2) indicated a key electrostatic binding interaction between the aromatic rings and Arg19, a residue that has been identified as essential for enzyme activity. © 2005 American Chemical Society.
Author(s): Sanchez-Sixto C, Prazeres VFV, Castedo L, Lamb H, Hawkins AR, Gonzalez-Bello C
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Year: 2005
Volume: 48
Issue: 15
Pages: 4871-4881
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
Publisher: American Chemical Society
URL: http://dx.doi.org/10.1021/jm0501836
DOI: 10.1021/jm0501836
PubMed id: 16033267
Altmetrics provided by Altmetric
